JP6411340B2 - 生殖補助における着床の成功を増大させる方法 - Google Patents

生殖補助における着床の成功を増大させる方法 Download PDF

Info

Publication number
JP6411340B2
JP6411340B2 JP2015522119A JP2015522119A JP6411340B2 JP 6411340 B2 JP6411340 B2 JP 6411340B2 JP 2015522119 A JP2015522119 A JP 2015522119A JP 2015522119 A JP2015522119 A JP 2015522119A JP 6411340 B2 JP6411340 B2 JP 6411340B2
Authority
JP
Japan
Prior art keywords
endometrial
uterine
expression
unk
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015522119A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015531057A (ja
JP2015531057A5 (https=
Inventor
レディー，ナタリー
ペティトバラト，マリー
Original Assignee
マトリスラブ イノーヴ
マトリスラブ イノーヴ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by マトリスラブ イノーヴ, マトリスラブ イノーヴ filed Critical マトリスラブ イノーヴ
Publication of JP2015531057A publication Critical patent/JP2015531057A/ja
Publication of JP2015531057A5 publication Critical patent/JP2015531057A5/ja
Application granted granted Critical
Publication of JP6411340B2 publication Critical patent/JP6411340B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1089—Design, preparation, screening or analysis of libraries using computer algorithms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/367—Infertility, e.g. sperm disorder, ovulatory dysfunction
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
JP2015522119A 2012-07-20 2013-07-19 生殖補助における着床の成功を増大させる方法 Active JP6411340B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12177377.4A EP2687851A1 (en) 2012-07-20 2012-07-20 Method for increasing implantation success in assisted fertilization
EP12177377.4 2012-07-20
PCT/EP2013/065355 WO2014013079A1 (en) 2012-07-20 2013-07-19 Method for increasing implantation success in assisted fertilization

Publications (3)

Publication Number Publication Date
JP2015531057A JP2015531057A (ja) 2015-10-29
JP2015531057A5 JP2015531057A5 (https=) 2016-09-01
JP6411340B2 true JP6411340B2 (ja) 2018-10-24

Family

ID=48874275

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015522119A Active JP6411340B2 (ja) 2012-07-20 2013-07-19 生殖補助における着床の成功を増大させる方法

Country Status (16)

Country Link
US (1) US10450561B2 (https=)
EP (2) EP2687851A1 (https=)
JP (1) JP6411340B2 (https=)
CN (1) CN104603622B (https=)
AU (1) AU2013291941B2 (https=)
BR (1) BR112015001157B1 (https=)
CA (1) CA2879467C (https=)
DK (1) DK2877856T3 (https=)
ES (1) ES2740548T3 (https=)
HU (1) HUE046835T2 (https=)
IL (1) IL236824B (https=)
PL (1) PL2877856T3 (https=)
PT (1) PT2877856T (https=)
RU (1) RU2730873C2 (https=)
SI (1) SI2877856T1 (https=)
WO (1) WO2014013079A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114927178A (zh) * 2015-06-12 2022-08-19 格尼亚Ip控股私人有限公司 患者和生物样本识别和追踪的方法和系统
WO2017054038A1 (en) 2015-09-30 2017-04-06 Prince Henry's Institute Of Medical Research Trading As The Hudson Institute Of Medical Research A method of treatment and prognosis
CN105784983B (zh) * 2016-01-13 2017-10-31 深圳中山生殖与遗传研究所 一种评估子宫内膜容受性的试剂盒及其使用方法
CZ2017255A3 (cs) 2017-05-04 2018-11-14 Zentiva, K.S. Filmem potažené tablety Deferasiroxu
EP3914915A1 (en) * 2019-01-25 2021-12-01 Fertility Lab Sciences, LLC Uterine endometrial fluid for prediction of success in fertility treatment
CN110042156B (zh) 2019-04-22 2021-12-28 苏州亿康医学检验有限公司 一种判断子宫内膜容受性的方法及其应用
CN110148446B (zh) * 2019-05-21 2023-06-16 重庆市柏玮熠科技有限公司 Ivf样本核对系统
CN114599798A (zh) * 2019-06-25 2022-06-07 哈德逊医学研究所 预测子宫内膜容受性的方法
GB201911947D0 (en) * 2019-08-20 2019-10-02 Univ Warwick Miscarriage biomarkers
RU2732432C1 (ru) * 2020-03-31 2020-09-16 Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) Способ оценки эндометриальной дисфункции у женщин с первичным эндометриоз-ассоциированным бесплодием
CN111624354A (zh) * 2020-06-05 2020-09-04 佛山迪安医学检验实验室有限公司 一种诊断试剂盒及诊断方法
CN111772682B (zh) * 2020-07-10 2021-08-13 北京大学第三医院（北京大学第三临床医学院） 预测受试者出现卵巢储备新变化年限的系统和方法
CN111778326B (zh) * 2020-07-14 2021-10-22 和卓生物科技（上海）有限公司 用于子宫内膜容受性评估的基因标志物组合及其应用
RU2748191C1 (ru) * 2021-01-21 2021-05-20 Мекан Рахимбердыевич Оразов Способ определения степени выраженности хронического эндометрита у женщин с маточным фактором бесплодия после неудачного экстракорпорального оплодотворения в анамнезе (варианты)
EP4407626A1 (fr) * 2023-01-30 2024-07-31 Sofia Procédé de génération de recommandations diagnostiques et/ou thérapeutiques en fertilité

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1004154B (el) * 2001-05-21 2003-02-20 Μεθοδος διερευνησης του ενδομητριου με εξετασεις που εφαρμοζονται επι του ιστου αποπεπτωκοτος ενδομητριου (ιστου περιοδου)
US7175990B2 (en) 2002-02-26 2007-02-13 The Regents Of The University Of California Method of determining endometrial receptivity
US20100150862A1 (en) * 2006-12-07 2010-06-17 Schering Corporation Methods of modulating maternal-fetal tolerance
CN105224827B (zh) * 2008-07-01 2019-12-24 小利兰·斯坦福大学托管委员会 用于发展ivf治疗协议的分析数据的计算机系统和存储介质
WO2010010201A1 (es) 2008-07-22 2010-01-28 Equipo Ivi Investigacion Sl Perfil de expresion genetica como marcador de la receptividad endometrial
WO2011000805A1 (en) * 2009-06-29 2011-01-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Biomarkers of oocyte competency and method of use
EP2348318A1 (en) 2010-01-21 2011-07-27 Equipo Ivi Investigación, S.L. Diagnostic method for endometrial receptivity
JP6219164B2 (ja) * 2010-05-27 2017-10-25 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 患者の子宮内膜の受容性を評価するための方法
BR112013000879A2 (pt) * 2010-07-13 2016-05-17 Univfy Inc método de avaliação do risco de nascimento múltiplos em travamentos para infertilidade
RU2444315C1 (ru) * 2010-09-03 2012-03-10 Михаил Григорьевич Шнейдерман Способ повышения возможности удачной имплантации эмбриона к эндометрию полости матки

Also Published As

Publication number Publication date
PL2877856T3 (pl) 2019-11-29
BR112015001157B1 (pt) 2022-03-29
CA2879467C (en) 2021-11-09
EP2877856A1 (en) 2015-06-03
JP2015531057A (ja) 2015-10-29
ES2740548T3 (es) 2020-02-05
SI2877856T1 (sl) 2019-11-29
US10450561B2 (en) 2019-10-22
IL236824B (en) 2018-06-28
DK2877856T3 (da) 2019-08-12
WO2014013079A1 (en) 2014-01-23
EP2877856B1 (en) 2019-07-10
HK1210835A1 (en) 2016-05-06
AU2013291941A1 (en) 2015-02-12
RU2730873C2 (ru) 2020-08-26
RU2016106004A (ru) 2017-12-08
BR112015001157A2 (https=) 2017-08-15
CN104603622B (zh) 2017-08-01
US20150184152A1 (en) 2015-07-02
CA2879467A1 (en) 2014-01-23
HUE046835T2 (hu) 2020-03-30
AU2013291941B2 (en) 2019-05-02
PT2877856T (pt) 2019-08-21
EP2687851A1 (en) 2014-01-22
CN104603622A (zh) 2015-05-06

Similar Documents

Publication Publication Date Title
JP6411340B2 (ja) 生殖補助における着床の成功を増大させる方法
Gnoth et al. Final ART success rates: a 10 years survey
Agenor et al. Infertility and miscarriage: common pathways in manifestation and management
Griesinger et al. Endometrial thickness on the day of embryo transfer is a poor predictor of IVF treatment outcome
Mascarenhas et al. Management of recurrent implantation failure: British Fertility Society policy and practice guideline
Marti-Garcia et al. Age-related uterine changes and its association with poor reproductive outcomes: a systematic review and meta-analysis
Cheloufi et al. The endometrial immune profiling may positively affect the management of recurrent pregnancy loss
Wu et al. Bone morphogenetic protein-15 in follicle fluid combined with age may differentiate between successful and unsuccessful poor ovarian responders
Awonuga et al. Determinants of embryo implantation: roles of the endometrium and embryo in implantation success
Ozer et al. Prediction of risk factors for first trimester pregnancy loss in frozen-thawed good-quality embryo transfer cycles using machine learning algorithms
Bhatti et al. The amniotic fluid cell-free transcriptome in spontaneous preterm labor
Jain et al. Mucosal biomarkers for endometrial receptivity: A promising yet underexplored aspect of reproductive medicine
Ganer Herman et al. Does embryo quality at transfer affect obstetric outcomes and placental findings?
Allegra et al. Endometrial expression of selected genes in patients achieving pregnancy spontaneously or after ICSI and patients failing at least two ICSI cycles
El-Halawaty et al. Assessment of male serum anti-Mullerian hormone as a marker of spermatogenesis and ICSI outcome
Dumancic et al. Histopathologic characteristics of term placentas in singleton pregnancies in women with endometriosis-related infertility after ART treatment: case-control study
Kaser et al. When is clomiphene or gonadotropin intrauterine insemination futile? Results of the Fast Track and Standard Treatment Trial and the Forty and Over Treatment Trial, two prospective randomized controlled trials
Simpson et al. Peri‐implantation cytokine profile differs between singleton and twin IVF pregnancies
Ibis et al. Testicular sperm retrieval for intracytoplasmic sperm injection: when to consider it after unsuccessful intracytoplasmic sperm injection with ejaculated sperm?
Wong et al. Do uterine natural killer cell numbers in peri-implantation endometrium predict hypertensive disorder in pregnancy in women with a history of reproductive failure?
Løssl et al. Predictive value of plasma human chorionic gonadotropin measured 14 days after Day‐2 single embryo transfer
Zhang et al. Predictive value of anti-Müllerian hormone on pregnancy outcomes in in-vitro fertilization/intracytoplasmic single sperm injection patients at different ages
Stankewicz Optimizing IVF by controlling for both embryonic aneuploidy and endometrial receptivity using genetic testing
Godinho et al. Comparison of clinical outcome after intrauterine insemination with donor semen in single women, lesbian couples and heterosexual couples
Kumar et al. Ovarian interleukin profile and pregnancy outcome in women undergoing assisted reproduction: A prospective study

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150611

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160714

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160714

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170425

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170428

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170721

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171226

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180322

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180522

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180904

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180926

R150 Certificate of patent or registration of utility model

Ref document number: 6411340

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250